1f
12
9
1a
8
20
8
49
16
8
19
1
49
2
8
1b
1d
18
89
2d
1d
2 29
1d
25
2d
David A Wolk, MD
3bProfessor of Neurology
28
78
3
60
Attending Neurologist, Hospital of the University of Pennsylvania
7d
Faculty, Center for Cognitive Neuroscience, University of Pennsylvania
6d
Fellow, Institute on Aging, University of Pennsylvania
56
Co-Director, Penn Memory Center
69
Director, Penn Alzheimer's Disease Research Center
76
Division Chief, Cognitive Neurology, University of Pennsylvania
5b
Co-Director, Penn Institute on Aging
11
Department: Neurology
4
1
b
1d
46
Contact information
40
4
3
23
40
Penn Memory Center
15 Ralston House
d #212A
37 3615 Chestnut Street
Philadelphia, PA 19104
26
15 Ralston House
d #212A
37 3615 Chestnut Street
Philadelphia, PA 19104
2e
Office: 215 662-7810
32 Fax: 215 662-7812
24
93
32 Fax: 215 662-7812
24
Email:
david.wolk@uphs.upenn.edu
12
david.wolk@uphs.upenn.edu
1f
Graduate Group Affiliations
8
3
3
2
4
b
1f
-
64
- Neuroscience 41
- Bioengineering e
13
Education:
21 7 BA 17 (Psychology) c
2a Dartmouth College, 1994.
21 7 MD 15 (Medicine) c
44 Johns Hopkins University School of Medicine, 1998.
c
3
3
21
21 7 BA 17 (Psychology) c
2a Dartmouth College, 1994.
21 7 MD 15 (Medicine) c
44 Johns Hopkins University School of Medicine, 1998.
c
1f
Post-Graduate Training
24 77 Intern in Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1998-1999.
24 71 Resident in Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1999-2002.
24 7c Fellow in Cognitive Neurology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 2002-2004.
24 88 Post-doctoral Research Fellow, Harvard University, Cambridge, MA, Brigham and Women's Hospital, Boston, MA, 2003-2006.
c
3
25
24 77 Intern in Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 1998-1999.
24 71 Resident in Neurology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1999-2002.
24 7c Fellow in Cognitive Neurology, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, 2002-2004.
24 88 Post-doctoral Research Fellow, Harvard University, Cambridge, MA, Brigham and Women's Hospital, Boston, MA, 2003-2006.
c
17
Certifications
28 46 Diplomate of the American Board of Psychiatry And Neurology, Inc. 16 , 2003.
28 92 Subspecialty Certification in Behavioral Neurology and Neuropsychiatry by the United Council of Neurologic Subspecialties, 2012.
c
3
8a
Permanent link28 46 Diplomate of the American Board of Psychiatry And Neurology, Inc. 16 , 2003.
28 92 Subspecialty Certification in Behavioral Neurology and Neuropsychiatry by the United Council of Neurologic Subspecialties, 2012.
c
2 29
21
1e
1d
24
5e
65
1a 29
27
Description of Research Expertise
b5 Episodic Memory, Event-related Potentials, transcranial direct current stimulation, MRI, Alzheimer's Disease, Dementia, Memory Disorders, Cognitive Neurology, Aging,65
Description of Clinical Expertise
54 Alzheimer's Disease, Dementia, Memory Disorders, Cognitive Neurology1a 29
23
1cc Wolk DA, Dickerson BC: Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 107(22): 10256-61, Jun 2010 Notes: Featured article in Alzheimer Research Forum: ApoE and Brain Networks—The Anatomy of a Risk Factor, May 28, 2010.
10e Wolk DA, Dunfee KL, Dickerson BC, Aizenstein HJ, Dekosky ST: A medial temporal lobe division of labor: Insights from memory in aging and early Alzheimer disease. Hippocampus 21(5): 461-6, Mar 2010.
130 Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, DeKosky ST: Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology 65(5): 557-68, May 2009.
168 Dickerson BC, Wolk DA: MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology 78(2): 84-90, Dec 2011 Notes: Featured editorial on manuscript: Resnick SM; Scheltens P. MRI-based biomarkers of preclinical AD: An Alzheimer signature. Neurology: 78(2): 80-81. 2 8f Featured article in Alzheimer Research Forum. Is Structural MRI Closing In on Preclinical AD Biomarker? December 27, 2011.
127 Pluta J, Yushkevich P, Das S, Wolk D: In vivo Analysis of Hippocampal Subfield Atrophy in Mild Cognitive Impairment via Semi-Automatic Segmentation of T2-Weighted MRI. Journal of Alzheimer's Disease 31(1): 85-99, Jan 2012.
10e Wolk DA, Price JC, Madeira C, Saxton JA, Snitz BE, Lopez OL, Mathis CA, Klunk WE, Dekosky ST: Amyloid imaging in dementias with atypical presentation. Alzheimer's & Dementia 8(5): 389-98, Jan 2012.
101 Wolk DA, Mancuso L, Kliot D, Arnold SE, Dickerson BC: Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD. Neuropsychologia 51(6): 1094-102, Mar 2013.
2c
7
1d
1f
Selected Publications
c1 Wolk DA, Dickerson BC : Fractionating verbal episodic memory in Alzheimer's disease. NeuroImage 54(2): 1530-9, Sep 2010.1cc Wolk DA, Dickerson BC: Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 107(22): 10256-61, Jun 2010 Notes: Featured article in Alzheimer Research Forum: ApoE and Brain Networks—The Anatomy of a Risk Factor, May 28, 2010.
10e Wolk DA, Dunfee KL, Dickerson BC, Aizenstein HJ, Dekosky ST: A medial temporal lobe division of labor: Insights from memory in aging and early Alzheimer disease. Hippocampus 21(5): 461-6, Mar 2010.
130 Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, DeKosky ST: Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology 65(5): 557-68, May 2009.
168 Dickerson BC, Wolk DA: MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology 78(2): 84-90, Dec 2011 Notes: Featured editorial on manuscript: Resnick SM; Scheltens P. MRI-based biomarkers of preclinical AD: An Alzheimer signature. Neurology: 78(2): 80-81. 2 8f Featured article in Alzheimer Research Forum. Is Structural MRI Closing In on Preclinical AD Biomarker? December 27, 2011.
127 Pluta J, Yushkevich P, Das S, Wolk D: In vivo Analysis of Hippocampal Subfield Atrophy in Mild Cognitive Impairment via Semi-Automatic Segmentation of T2-Weighted MRI. Journal of Alzheimer's Disease 31(1): 85-99, Jan 2012.
10e Wolk DA, Price JC, Madeira C, Saxton JA, Snitz BE, Lopez OL, Mathis CA, Klunk WE, Dekosky ST: Amyloid imaging in dementias with atypical presentation. Alzheimer's & Dementia 8(5): 389-98, Jan 2012.
101 Wolk DA, Mancuso L, Kliot D, Arnold SE, Dickerson BC: Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD. Neuropsychologia 51(6): 1094-102, Mar 2013.
2c